ERIS Lifesciences Ltd
company logo

ERIS Lifesciences Ltd

Pharmaceuticals
Mid Cap

-

- (0%)


ERIS Lifesciences Ltd Performance

-

-

-

-


-

-

-

-

-

ERIS Lifesciences Ltd Fundamentals

13,801.41Cr

35.20

5.34

0.23

28.81

-%

190.05

i buttonClick here to know more about Fundamentals

ERIS Lifesciences Ltd Financials

ERIS Lifesciences Ltd Financialsright-arrow

ERIS Lifesciences Ltd Shareholding Pattern

ERIS Lifesciences Ltd Delivery and Volume

About ERIS Lifesciences Ltd

Eris Lifesciences Limited was incorporated on January 25, 2007. Subsequently, the name of the company was changed to 'Eris Lifesciences Private Limited' on February 9, 2007. Further, the Company was converted into a Public Limited cCompany and the name was changed to 'Eris Lifesciences Limited' on F

-

2007

ERIS

NameDesignation
Amit Indubhushan BakshiCMD & Executive Director
Kaushal Kamlesh ShahWTD & Executive Director
Inderjeet Singh NegiWTD & Executive Director
Krishnakumar VaidyanathanExecutive Director / WTD / Chi
Sujesh VasudevanIndependent Non Exe. Director
Prashant GuptaIndependent Non Exe. Director
Rajeev Narotam DalalIndependent Non Exe. Director
Kalpana UnadkatIndependent Non Exe. Director
News and Events...

Similar Stocks

What's Trending

ERIS Lifesciences Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase ERIS Lifesciences Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. ERIS Lifesciences Ltd's share price is ₹1015.45 as of 2024-07-17.
ERIS Lifesciences Ltd's P/E ratio is 35.2 times as of 2024-07-17.
ERIS Lifesciences Ltd's most recent financial reports indicate a price-to-book ratio of 5.34, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. ERIS Lifesciences Ltd's market capitalization is ₹13801.41 Cr as on 2024-07-17.
The current financial records of ERIS Lifesciences Ltd show a 19.23% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to ERIS Lifesciences Ltd's most recent financial filings, the company has a total asset value of ₹921.21, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a ERIS Lifesciences Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. ERIS Lifesciences Ltd's 52-week high and low as of 2024-07-17 are ₹1043 and ₹1003.2, respectively.